MLB Lawsuit May Inadvertently Target Players

MLB Lawsuit May Inadvertently Target Players

Major League Baseball’s recent lawsuit against Florida clinic BioGenesis may have unintended consequences for players, a new report shows.

MLB is currently suing the clinic for allegedly providing banned performance-enhancing drugs to the league’s players, a heavy sports law violation. Court documents show that MLB believes BioGenesis owner Anthony Bosch gave illicit performance enhancing drugs to nearly half a dozen players, according to Reuters. However, if the suit continues, the clinic may be forced to disclose medical records of players that visited the clinic, which could lead to disciplinary actions if it’s discovered that these players accepted these drugs, Reuters reports.

The league claims that by providing drugs to players, the action amounts to contract interference by “inducing” players to violate MLB’s drug prevention program. However, Reuters notes that these types of cases – which are typically used to go after business competitors – are difficult to win. Despite this analysis, the MLB said the case “has merit” and does not plan on shying away.

“We believe we have a legitimate legal claim against the defendants and we intend to pursue it vigorously,” said MLB spokesman Pat Courtney.